Key Financial Data Of Group

Modalis Therapeutics Corporation - Filing #7609137

Concept 2022-01-01 to
2022-03-31
As at
2022-03-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-443,703,000 JPY
-1,231,299,000 JPY
-245,810,000 JPY
Profit (loss) attributable to owners of parent
-438,906,000 JPY
-738,956,000 JPY
201,800,000 JPY
Comprehensive income
-427,484,000 JPY
-731,801,000 JPY
210,004,000 JPY
Net assets
5,126,352,000 JPY
5,549,212,000 JPY
6,430,153,000 JPY
Total assets
5,624,061,000 JPY
6,069,137,000 JPY
6,533,474,000 JPY
Basic earnings (loss) per share
-15.13
-25.70
7.07
Diluted earnings per share
6.66
Equity-to-asset ratio
0.912 xbrli:pure
0.914 xbrli:pure
0.984 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.